[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Basma Rabiey\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100524709","early-phase-1-comparison-between-haparin-and-herodin-in-hd-100524709",false,"NCT06112262","Comparison Between Haparin and Herodin in HD","Comparison of the Effecta and Drawbacks of Heparin Versus Hirudin Drugs in Haemodialysis Patients in Assiut University Hospitals","Inclusion Criteria:\n\n1. patient age between 18:70\n2. Haemodialysis duration less than 6 months\n3. Agree to participate in the study\n\nExclusion Criteria:\n\n1. AKI\n2. patients with impaired coagulation profile\n3. Decompensated liver disease","ALL","18 Years","70 Years",{"count":20,"type":21},98,"ESTIMATED","INTERVENTIONAL",[24],"EARLY_PHASE1","The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is:\n\nwhich drug is more safe in Haemodialysis?",[27],"Haemodialysis","NOT_YET_RECRUITING","2023-11-19",{"date":31,"type":32},"2023-11-21","ACTUAL",{"date":34,"type":21},"2023-12-20",{"date":36,"type":21},"2026-09",{"name":38,"class":39},"Basma Rabiey","OTHER",""]